The role of parathyroid hormone (PTH) and vitamin D in falls and hip fracture type

  • Konstantinos Dretakis
  • Vasilios G. IgoumenouEmail author
Original Article



Fragility fractures of the hip are associated with high morbidity and mortality, and represent a rather devastating consequence of osteoporosis. Hip fractures are traditionally investigated as a whole, although it has been recently implied that distinct pathogenic mechanisms may lead either to trochanteric or subcapital fractures.


To investigate whether differences exist by hip fracture type with respect to serum 25(OH)D (vitamin D) and parathyroid hormone (PTH) levels, in addition to epidemiological and demographic data, including history of falls.


The inclusion criteria were met by 116 patients [48 men and 68 women; mean age 80.8 ± 8.5 (range 62–94) years]. Patients were analyzed according to hip fracture type, history of falls, and vitamin D and PTH status.


Older age, recurrent falls, serum levels of PTH > 65 pg/ml, and severe vitamin D deficiency were found to be associated with trochanteric fractures. Additionally, older age, female gender, PTH > 65 pg/ml, and severe vitamin D deficiency were related to recurrent falls. Meanwhile, patients with absence of PTH response to low vitamin D levels, were not repeated fallers and suffered mostly from subcapital fractures.

Discussion and conclusion

Elevated PTH levels predispose both to falls and trochanteric fractures, while vitamin D-deficient patients with normal PTH levels are mostly related to subcapital fractures. It is thereby indicated that different pathophysiological processes lie behind subcapital and trochanteric fractures. A better understanding of these mechanisms may assist in the development of prevention strategies for individuals recognized at risk for falls and either type of hip fracture.


Parathyroid hormone (PTH) 25 (OH) vitamin D Hip fracture type Falls 



The authors would like to thank Nikolaos Kolaitis, MD, PhD, for his contribution in the statistical analysis of this paper.

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest. No benefits have been or will be received from a commercial party related directly or indirectly to the subject matter of this article.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 25:2359–2381. CrossRefGoogle Scholar
  2. 2.
    (US) OotSG (2004) Bone Health and Osteoporosis: A Report of the Surgeon General. Office of the Surgeon General (US). Accessed 18 Jan 2017
  3. 3.
    Tsuda T (2017) Epidemiology of fragility fractures and fall prevention in the elderly: a systematic review of the literature. Curr Orthop Pract 28:580–585. CrossRefGoogle Scholar
  4. 4.
    Aguado-Maestro I, Panteli M, García-Alonso M et al (2017) Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures. Injury 48:S27–S33. CrossRefGoogle Scholar
  5. 5.
    Farmer RP, Herbert B, Cuellar DO et al (2014) Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients’ bone health. Int Orthop 38:1731–1738. CrossRefGoogle Scholar
  6. 6.
    Feng Y, Cheng G, Wang H et al (2017) The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture. Osteoporos Int 28:1641–1652. CrossRefGoogle Scholar
  7. 7.
    Pulkkinen P, Gluer CC, Jamsa T (2011) Investigation of differences between hip fracture types: a worthy strategy for improved risk assessment and fracture prevention. Bone 49:600–604. CrossRefGoogle Scholar
  8. 8.
    Mazziotti G, Biagioli E, Maffezzoni F et al (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100:384–394. CrossRefGoogle Scholar
  9. 9.
    Johansson H, Kanis JA, Oden A et al (2014) A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 29:223–233. CrossRefGoogle Scholar
  10. 10.
    Qu X, Zhang X, Zhai Z et al (2014) Association between physical activity and risk of fracture. J Bone Miner Res 29:202–211. CrossRefGoogle Scholar
  11. 11.
    Thorin MH, Wihlborg A, Akesson K et al (2016) Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 27:249–255. CrossRefGoogle Scholar
  12. 12.
    Di Monaco M, Castiglioni C, Tappero R (2016) Parathyroid hormone response to severe vitamin D deficiency is associated with femoral neck bone mineral density: an observational study of 405 women with hip-fracture. Hormones (Athens) 15:527–533. CrossRefGoogle Scholar
  13. 13.
    Fisher A, Srikusalanukul W, Davis M et al (2010) Hip fracture type: important role of parathyroid hormone (PTH) response to hypovitaminosis D. Bone 47:400–407. CrossRefGoogle Scholar
  14. 14.
    Fisher AA, Srikusalanukul W, Davis MW et al (2012) Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences. J Trauma Manag Outcomes 6:2. CrossRefGoogle Scholar
  15. 15.
    Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. CrossRefGoogle Scholar
  16. 16.
    Sahota O, Gaynor K, Harwood RH et al (2001) Hypovitaminosis D and ‘functional hypoparathyroidism’-the NoNoF (Nottingham Neck of Femur) study. Age Ageing 30:467–472CrossRefGoogle Scholar
  17. 17.
    Sakuma M, Endo N, Oinuma T (2007) Serum 25-OHD insufficiency as a risk factor for hip fracture. J Bone Miner Metab 25:147–150. CrossRefGoogle Scholar
  18. 18.
    Sakuma M, Endo N, Oinuma T et al (2006) Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 17:1608–1614. CrossRefGoogle Scholar
  19. 19.
    Guerra MT, Feron ET, Viana RD et al (2016) Elderly with proximal hip fracture present significantly lower levels of 25-hydroxyvitamin D. Rev Bras Ortop 51:583–588. CrossRefGoogle Scholar
  20. 20.
    Michaelsson K, Weiderpass E, Farahmand BY et al (1999) Differences in risk factor patterns between cervical and trochanteric hip fractures. Swedish Hip Fracture Study Group. Osteoporos Int 10:487–494CrossRefGoogle Scholar
  21. 21.
    Tal S, Gurevich A, Sagiv S et al (2015) Differential impact of some risk factors on trochanteric and cervical hip fractures. Geriatr Gerontol Int 15:443–448. CrossRefGoogle Scholar
  22. 22.
    Hernandez JL, Olmos JM, Alonso MA et al (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470. CrossRefGoogle Scholar
  23. 23.
    Jokinen H, Pulkkinen P, Korpelainen J et al (2010) Risk factors for cervical and trochanteric hip fractures in elderly women: a population-based 10-year follow-up study. Calcif Tissue Int 87:44–51. CrossRefGoogle Scholar
  24. 24.
    Lin WP, Wen CJ, Jiang CC et al (2011) Risk factors for hip fracture sites and mortality in older adults. J Trauma 71:191–197. CrossRefGoogle Scholar
  25. 25.
    Dretakis OE, Margioris AN, Tsatsanis C et al (2011) Elderly patients with trochanteric hip fracture have lower serum Vitamin D levels compared to patients with cervical hip fracture. Arch Gerontol Geriatr 52:e15–e18. CrossRefGoogle Scholar
  26. 26.
    Alarcon T, Gonzalez-Montalvo JI, Hoyos R et al (2015) Parathyroid hormone response to two levels of vitamin D deficiency is associated with high risk of medical problems during hospitalization in patients with hip fracture. J Endocrinol Invest 38:1129–1135. CrossRefGoogle Scholar
  27. 27.
    Manson JE, Brannon PM, Rosen CJ et al (2016) Vitamin D deficiency—is there really a pandemic? New Engl J Med 375:1817–1820. CrossRefGoogle Scholar
  28. 28.
    IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC. Google Scholar
  29. 29.
    Aloia JF, Feuerman M, Yeh JK (2006) Reference range for serum parathyroid hormone. Endocr Pract 12:137–144. CrossRefGoogle Scholar
  30. 30.
    Gonnelli S, Caffarelli C, Maggi S et al (2013) The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study. Osteoporos Int 24:1151–1159. CrossRefGoogle Scholar
  31. 31.
    Duboeuf F, Hans D, Schott AM et al (1997) Different morphometric and densitometric parameters predict cervical and trochanteric hip fracture: the EPIDOS Study. J Bone Miner Res 12:1895–1902. CrossRefGoogle Scholar
  32. 32.
    Cauley JA, Lui LY, Genant HK et al (2009) Risk factors for severity and type of the hip fracture. J Bone Miner Res 24:943–955. CrossRefGoogle Scholar
  33. 33.
    Karagiannis A, Papakitsou E, Dretakis K et al (2006) Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type of fracture. Calcif Tissue Int 78:72–77. CrossRefGoogle Scholar
  34. 34.
    Tanner DA, Kloseck M, Crilly RG et al (2010) Hip fracture types in men and women change differently with age. BMC Geriatr 10:12. CrossRefGoogle Scholar
  35. 35.
    Fox KM, Magaziner J, Hebel JR et al (1999) Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci 54:M635–M640CrossRefGoogle Scholar
  36. 36.
    Haentjens P, Autier P, Barette M et al (2007) Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone 41:958–964. CrossRefGoogle Scholar
  37. 37.
    Baudoin C, Fardellone P, Sebert JL (1993) Effect of sex and age on the ratio of cervical to trochanteric hip fracture. A meta-analysis of 16 reports on 36,451 cases. Acta Orthop Scand 64:647–653CrossRefGoogle Scholar
  38. 38.
    Crilly RG, Kloseck M, Mequanint S (2016) Hip fracture types in Canadian men and women change differently with age: a population-level analysis. Clin Med Insights Arthritis Musculoskelet Disord 9:75–79. CrossRefGoogle Scholar
  39. 39.
    Cummings SR, Nevitt MC (1994) Non-skeletal determinants of fractures: the potential importance of the mechanics of falls. Study of Osteoporotic Fractures Research Group. Osteoporos Int 4:67–70CrossRefGoogle Scholar
  40. 40.
    Malasana G, Brignole M, Daccarett M et al (2011) The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin Electrophysiol 34:278–283. CrossRefGoogle Scholar
  41. 41.
    Ghose RR (2005) Vitamin D deficiency and muscle weakness in the elderly. N Z Med J 118:U1582Google Scholar
  42. 42.
    Koeckhoven E, van der Leeden M, Roorda LD et al (2016) The Association Between Serum 25-hydroxy Vitamin D Level and Upper Leg Strength in Patients with Knee Osteoarthritis: Results of the Amsterdam Osteoarthritis Cohort. J Rheumatol 43:1400–1405. CrossRefGoogle Scholar
  43. 43.
    Orces CH (2017) Prevalence of clinically relevant muscle weakness and its association with vitamin D status among older adults in Ecuador. Aging Clin Exp Res 29:943–949. CrossRefGoogle Scholar
  44. 44.
    Snijder MB, van Schoor NM, Pluijm SM et al (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91(8):2980–2985. CrossRefGoogle Scholar
  45. 45.
    Tanner SB, Harwell SA (2015) More than healthy bones: a review of vitamin D in muscle health. Ther Adv Musculoskelet Dis 7:152–159. CrossRefGoogle Scholar
  46. 46.
    Di Monaco M, Vallero F, De Toma E et al (2012) Adherence to recommendations for fall prevention significantly affects the risk of falling after hip fracture: post-hoc analyses of a quasi-randomized controlled trial. Eur J Phys Rehabil Med 48:9–15Google Scholar
  47. 47.
    Stein MS, Wark JD, Scherer SC et al (1999) Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 47:1195–1201CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Second Department of OrthopaedicsHygeia HospitalAthensGreece
  2. 2.First Department of Orthopaedics, School of MedicineNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations